Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Perlmutter

Showing results (561-570 of 570) with videos related to

Pageof 57
Sort By:
You have reached the last page of results.This site can display upto 570 results.
Neurology|May 30, 2008
Haplotypes and gene expression implicate the MAPT region for Parkinson disease: the GenePD StudyJ E Tobin, J C Latourelle, M F Lew, et al.
Nature Genetics|July 28, 2014
Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's diseaseMike A Nalls, Nathan Pankratz, Christina M Lill, et al.
Annals of Clinical and Translational Neurology|June 19, 2025
Genetic Diversity and Expanded Phenotypes in Dystonia: Insights From Large-Scale Exome SequencingMirja Thomsen, Fabian Ott, Sebastian Loens, et al.
BMC Medicine|November 7, 2008
The Gly2019Ser mutation in LRRK2 is not fully penetrant in familial Parkinson's disease: the GenePD studyJeanne C Latourelle, Mei Sun, Mark F Lew, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 28, 2021
A Multi-center Genome-wide Association Study of Cervical DystoniaYan V Sun, Chengchen Li, Qin Hui, et al.
Neurology|December 4, 2016
A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington diseaseAndrew McGarry, Michael McDermott, Karl Kieburtz, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 17, 2024
Genetic Risk Factors in Isolated Dystonia Escape Genome-Wide Association StudiesBjörn-Hergen Laabs, Katja Lohmann, Eva-Juliane Vollstedt, et al.
Journal of Clinical Medicine|November 19, 2020
Safety and Tolerability of SRX246, a Vasopressin 1a Antagonist, in Irritable Huntington's Disease Patients-A Randomized Phase 2 Clinical TrialMichael J Brownstein, Neal G Simon, Jeffrey D Long, et al.
JAMA Neurology|November 17, 2015
Clinical-Genetic Associations in the Prospective Huntington at Risk Observational Study (PHAROS): Implications for Clinical Trials, Kevin Michael Biglan, Ira Shoulson, et al.
JAMA Neurology|March 26, 2014
A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit, M Flint Beal, David Oakes, et al.
Pageof 57

Showing results (561-570 of 570) with videos related to

Sort By:
Pageof 57
You have reached the last page of results.This site can display upto 570 results.
Neurology|May 30, 2008
Haplotypes and gene expression implicate the MAPT region for Parkinson disease: the GenePD StudyJ E Tobin, J C Latourelle, M F Lew, et al.
Nature Genetics|July 28, 2014
Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's diseaseMike A Nalls, Nathan Pankratz, Christina M Lill, et al.
Annals of Clinical and Translational Neurology|June 19, 2025
Genetic Diversity and Expanded Phenotypes in Dystonia: Insights From Large-Scale Exome SequencingMirja Thomsen, Fabian Ott, Sebastian Loens, et al.
BMC Medicine|November 7, 2008
The Gly2019Ser mutation in LRRK2 is not fully penetrant in familial Parkinson's disease: the GenePD studyJeanne C Latourelle, Mei Sun, Mark F Lew, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 28, 2021
A Multi-center Genome-wide Association Study of Cervical DystoniaYan V Sun, Chengchen Li, Qin Hui, et al.
Neurology|December 4, 2016
A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington diseaseAndrew McGarry, Michael McDermott, Karl Kieburtz, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 17, 2024
Genetic Risk Factors in Isolated Dystonia Escape Genome-Wide Association StudiesBjörn-Hergen Laabs, Katja Lohmann, Eva-Juliane Vollstedt, et al.
Journal of Clinical Medicine|November 19, 2020
Safety and Tolerability of SRX246, a Vasopressin 1a Antagonist, in Irritable Huntington's Disease Patients-A Randomized Phase 2 Clinical TrialMichael J Brownstein, Neal G Simon, Jeffrey D Long, et al.
JAMA Neurology|November 17, 2015
Clinical-Genetic Associations in the Prospective Huntington at Risk Observational Study (PHAROS): Implications for Clinical Trials, Kevin Michael Biglan, Ira Shoulson, et al.
JAMA Neurology|March 26, 2014
A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit, M Flint Beal, David Oakes, et al.
Pageof 57